StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.65+0.08 (+1.22%)

Close on Nov 18, 2026Market cap $308.41MP/E –Yield –

MapLight Therapeutics cash

Cash and short-term investments held at the end of each period.

MapLight Therapeutics's cash was $304.73M at Jun 30, 2026. For fiscal 2025 it was $453.10M, up 316.5% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$453.10M+316.5%
FY2024Dec 31, 2024$108.80M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$304.73M+180.1%
Q1 FY2026Mar 31, 2026$310.11M–
Q4 FY2025Dec 31, 2025$453.10M–
Q3 FY2025Sep 30, 2025$227.20M–
Q4 FY2024Dec 31, 2024$108.80M–

More MapLight Therapeutics figures

See a number that looks wrong?